Antibiotic susceptibility testing in less than 30 min using direct single-cell imaging

Proceedings of the National Academy of Sciences of the United States of America

Volumn 114, Issue 34, 2017, Pages 9170-9175

  Baltekin, Özden ^a   Boucharin, Alexis ^a   Tano, Eva ^a   Andersson, Dan I ^a   Elf, Johan ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Antibiotic; AST; Microfluidic; Point of care; Resistance; UTI

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; COTRIMOXAZOLE; DORIPENEM; FOSFOMYCIN; LEVOFLOXACIN; MECILLINAM; NITROFURANTOIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GROWTH RATE; HUMAN; MAJOR CLINICAL STUDY; MICROFLUIDICS; NONHUMAN; PHASE CONTRAST MICROSCOPY; POINT OF CARE TESTING; PRIORITY JOURNAL; SINGLE CELL ANALYSIS; TIME LAPSE IMAGING; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI; CLASSIFICATION; ESCHERICHIA COLI INFECTION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PHYSIOLOGY; PROCEDURES; REPRODUCIBILITY; STANDARDS;

ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; DRUG RESISTANCE, MICROBIAL; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; MICROBIAL SENSITIVITY TESTS; POINT-OF-CARE TESTING; REPRODUCIBILITY OF RESULTS; SINGLE-CELL ANALYSIS; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI;

EID: 85027889493     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1708558114     Document Type: Article

References (24)

1. Kerremans JJ, et al. (2008) Rapid identification and antimicrobial susceptibility testing reduce antibiotic use and accelerate pathogen-directed antibiotic use. J Antimicrob Chemother 61:428–435.
2. Doern GV, Scott DR, Rashad AL (1982) Clinical impact of rapid antimicrobial susceptibility testing of blood culture isolates. Antimicrob Agents Chemother 21:1023–1024.
3. van Belkum A, et al. (2013) Rapid clinical bacteriology and its future impact. Ann Lab Med 33:14–27.
4. Jenkins SG, Schuetz AN (2012) Current concepts in laboratory testing to guide antimicrobial therapy. Mayo Clin Proc 87:290–308.
5. Matuschek E, Brown DFJ, Kahlmeter G (2014) Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories. Clin Microbiol Infect 20:O255–O266.
6. Frickmann H, Masanta WO, Zautner AE (2014) Emerging rapid resistance testing methods for clinical microbiology laboratories and their potential impact on patient management. BioMed Res Int 2014:375681.
7. Reece A, et al. (2016) Microfluidic techniques for high throughput single cell analysis. Curr Opin Biotechnol 40:90–96.
8. Murray C, Adeyiga O, Owsley K, Di Carlo D (2015) Research highlights: Microfluidic analysis of antimicrobial susceptibility. Lab Chip 15:1226–1229.
9. Kim SC, Cestellos-Blanco S, Inoue K, Zare RN (2015) Miniaturized antimicrobial susceptibility test by combining concentration gradient generation and rapid cell culturing. Antibiotics (Basel) 4:455–466.
10. Choi J, et al. (2013) Rapid antibiotic susceptibility testing by tracking single cell growth in a microfluidic agarose channel system. Lab Chip 13:280–287.
11. Hou Z, et al. (2014) Time lapse investigation of antibiotic susceptibility using a microfluidic linear gradient 3D culture device. Lab Chip 14:3409–3418.
12. Choi J, et al. (2014) A rapid antimicrobial susceptibility test based on single-cell morphological analysis. Sci Transl Med 6:267ra174.
13. Quach DT, Sakoulas G, Nizet V, Pogliano J, Pogliano K (2016) Bacterial cytological profiling (BCP) as a rapid and accurate antimicrobial susceptibility testing method for Staphylococcus aureus. EBioMedicine 4:95–103.
14. Schoepp NG, et al. (2016) Digital quantification of DNA replication and chromosome segregation enables determination of antimicrobial susceptibility after only 15 minutes of antibiotic exposure. Angew Chem Int Ed Engl 55:9557–9561.
15. Stamm WE, Norrby SR (2001) Urinary tract infections: Disease panorama and challenges. J Infect Dis 183:S1–S4.
16. Wang P, et al. (2010) Robust growth of Escherichia coli. Curr Biol 20:1099–1103.
17. Slekovec C, et al. (2012) Impact of a region wide antimicrobial stewardship guideline on urinary tract infection prescription patterns. Int J Clin Pharm 34:325–329.
18. Schmiemann G, Kniehl E, Gebhardt K, Matejczyk MM, Hummers-Pradier E (2010) The diagnosis of urinary tract infection: A systematic review. Dtsch Arztebl Int 107: 361–367.
19. Marcusson LL, Frimodt-Møller N, Hughes D (2009) Interplay in the selection of fluo-roquinolone resistance and bacterial fitness. PLoS Pathog 5:e1000541.
20. Wallden M, Fange D, Lundius EG, Baltekin Ö, Elf J (2016) The synchronization of replication and division cycles in individual E. coli cells. Cell 166:729–739.
21. Kline KA, Lewis AL (2016) Gram-positive Uropathogens, polymicrobial urinary tract infection, and the emerging microbiota of the urinary tract. Microbial Spectr, 10.1128/microbiolspec.UTI-0012-2012.
22. Jaqaman K, et al. (2008) Robust single-particle tracking in live-cell time-lapse sequences. Nat Methods 5:695–702.
23. Loy G, Zelinsky A (2003) Fast radial symmetry for detecting points of interest. IEEE Trans Pattern Anal Mach Intell 25:959–973.
24. Seber GAF, Lee AJ (2003) Linear regression: Estimation and distribution theory. Linear Regression Analysis (Wiley, Hoboken, NJ), 2nd Ed. pp 35–95.